1. Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agents.
- Author
-
Chekhun VF, Lozovska YV, Burlaka AP, Ganusevich LI, Shvets YV, Lukyanova NY, Todor IM, Tregubova NA, and Naleskina LA
- Subjects
- Animals, Carcinoma 256, Walker genetics, Carcinoma 256, Walker metabolism, Carcinoma 256, Walker pathology, Drug Resistance, Neoplasm genetics, Female, Ferritins genetics, Ferritins metabolism, Matrix Metalloproteinase 2 genetics, Matrix Metalloproteinase 2 metabolism, Matrix Metalloproteinase 9 genetics, Matrix Metalloproteinase 9 metabolism, Neoplasm Transplantation, Rats, Rats, Inbred Strains, Reactive Oxygen Species metabolism, Transferrin genetics, Transferrin metabolism, Antibiotics, Antineoplastic pharmacology, Carcinoma 256, Walker drug therapy, Doxorubicin pharmacology, Drug Resistance, Neoplasm drug effects, Gene Expression Regulation, Neoplastic drug effects, Iron metabolism
- Abstract
The study was aimed at determining the changes of metal-containing proteins in blood serum and tumor tissue of animals with parental and doxorubicin-resistant strains of Walker-256 carcinosarcoma before and after the cytostatic administration. It has been shown that upon doxorubicin action the levels of total iron and transferrin in the tissues from the both groups of animals decreased while that of ferritine simultaneously increased with more pronounced pattern in the group of animals with resistant tumor strain. It has been shown that upon the action of doxorubicin in tumor tissue of animals with different sensitivity to the cytostatic there could be observed oppositely directed changes in the redox state of these cells that in turn determined the content of “ free iron” complexes, RO S generation and concentration of active forms of matrix metaloproteinase- 2 and matrix metaloproteinase-9, namely, the increase of these indexes in animals with parental strain and their decrease in animals with the resistant one. So, our study has demonstrated the remodulating effect of doxorubicin on the state of metal-containing proteins and redox characteristics of tumor dependent on its sensitivity to cytostatic, at the levels of the tumor and an organism. These data may serve as a criterion for the development of programs for the correction of malfunction of iron metabolism aimed at elevating tumor sensitivity to cytostatic agents.
- Published
- 2016
- Full Text
- View/download PDF